The magnitude of weight loss, in particular, was widely noted as approaching bariatric surgery outcomes, prompting discussion about the potential for pharmacotherapy to serve as an alternative or complement to surgical intervention for severe obesity
Methods Ethics statement This research was approved by the Institutional Review Board (IRB) of the University of California, San Francisco (UCSF), and all participants gave informed consent
If you have already read "GLP-1 Not Working
We addressed the rapid clearance of this transient hepatic lipid accumulation that could be due to the strong and acute activation of lipid export, manifested by the rise of plasma TGs that transiently peaked at 24 h post-injection
While needles remain an important barrier for some, our research shows theyre far from the only reason people arent using GLP-1 treatments
PlexusDx coordinates with your primary care physician or endocrinologist to share tirzepatide treatment details, enabling your thyroid specialist to make informed adjustments to hormone replacement if needed